VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ADXN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ADXNAddex Therapeutics Ltd
$6.00$4M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksADXNQuarterly Financials

Addex Therapeutics Ltd (ADXN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Addex Therapeutics Ltd (ADXN) quarterly income statement — complete revenue, gross profit & net income history

ADXN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue7.86K24829.72K36.38K01.51K53.84K115.28K233.48K153.45K327.73K630.88K500.89K592.43K409.42K183.35K237.24K397.49K682K992.6K
Revenue Growth %--83.55%-44.79%-68.45%-100%-99.02%-83.57%-81.73%-53.39%-74.1%-19.95%244.08%111.14%49.04%-39.97%-81.53%-71.9%-78.17%2401.47%15.31%
Cost of Goods Sold10.04K00234.45K0000000000000000
COGS % of Revenue127.68%--644.55%----------------
Gross Profit-2.18K24829.72K-198.08K01.51K53.84K115.28K233.48K153.45K327.73K630.88K500.89K592.43K409.42K183.35K237.24K397.49K682K992.6K
Gross Margin %-27.68%100%100%-544.55%-100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %--83.55%-44.79%-271.83%-100%-99.02%-83.57%-81.73%-53.39%-74.1%-19.95%244.08%111.14%49.04%-39.97%-81.53%-71.9%-78.17%2401.47%15.31%
Operating Expenses479.83K779.51K725.9K534.82K606.26K447.13K676.04K1.01M1.02M2.84M1.08M1.03M868.55K4.09M4.58M7.28M6M4.67M4.26M5.5M
OpEx % of Revenue6103.12%314318.95%2442.13%1470.29%-29650.8%1255.71%880.13%437.54%1848.06%328.61%162.8%173.4%690.52%1117.78%3968.04%2529.04%1175.61%624.31%554.03%
Selling, General & Admin389.31K567.98K459.92K411.96K448.07K260.57K337.25K507.17K571.74K1.7M473.99K593.04K504.75K-240.68K2.39M2.1M3.05M497.58K2.05M1.85M
SG&A % of Revenue4951.86%229024.6%1547.3%1132.53%-17278.91%626.42%439.95%244.88%1110.19%144.63%94%100.77%-40.63%583.81%1146.38%1284.88%125.18%301.16%186.05%
Research & Development9.39K3.86K85.26K68.49K32.58K-6.23K77.85K184.46K179.11K454.31K421.15K229.16K199.9K5.74M1.74M4.68M2.51M3.5M1.81M3.73M
R&D % of Revenue119.49%1556.05%286.83%188.29%--413.06%144.6%160.02%76.71%296.06%128.5%36.32%39.91%969.44%424.44%2550.97%1056.83%880.12%264.72%375.97%
Other Operating Expenses81.12K207.67K180.72K54.37K125.61K192.8K260.94K322.97K270.72K677.95K181.83K204.86K163.89K-1000K448.44K496.33K444.42K676.95K398.52K-79.28K
Operating Income-479.83K-779.26K-696.17K-732.9K-606.26K-445.63K-622.2K-899.32K-788.09K-2.68M-749.24K-396.18K-367.66K-3.5M-4.17M-7.09M-5.76M-4.28M-3.58M-4.51M
Operating Margin %-6103.12%-314218.95%-2342.13%-2014.84%--29550.8%-1155.71%-780.13%-337.54%-1748.06%-228.61%-62.8%-73.4%-590.52%-1017.78%-3868.04%-2429.04%-1075.61%-524.31%-454.03%
Operating Income Growth %20.85%-74.87%-11.89%18.5%23.07%83.39%16.96%-127%-114.36%23.33%82.02%94.41%93.62%18.17%-16.53%-57.37%-83.05%-126.97%-14.87%-51.54%
EBITDA-470.01K-777.14K-694.06K-730.78K-604.14K-421.82K-568.62K-786.93K-717.73K-2.6M-673.86K-320.77K-291.88K-3.42M-4.09M-7.01M-5.68M-4.19M-3.49M-4.42M
EBITDA Margin %-5978.21%-313364.92%-2335.01%-2009.02%--27972.35%-1056.2%-682.65%-307.41%-1696.32%-205.61%-50.85%-58.27%-577.75%-998.9%-3822.59%-2392.44%-1054.74%-511.45%-445.13%
EBITDA Growth %22.2%-84.23%-22.06%7.14%15.83%83.79%15.62%-145.32%-145.9%23.95%83.52%95.42%94.86%18.36%-17.25%-58.63%-85.52%-133.36%-15.73%-53.55%
D&A (Non-Cash Add-back)9.82K2.12K2.12K2.12K2.12K23.8K53.58K112.38K70.36K79.39K75.38K75.41K75.78K75.65K77.32K83.35K86.83K82.97K87.74K88.26K
EBIT-1.71M-1.83M-1.58M-1.96M-1.47M-1.19M-1.53M-1.46M-734.57K-2.85M-710.2K-520.73K-369.4K-3.64M-4.1M-7.21M-5.8M-4.41M-3.59M-4.67M
Net Interest Income-3.07K-575-472-826-548-1.5K-4846436.96K4.78K10.15K9.52K23.22K17.58K-2.78K-12.13K-22.32K-8.59K-8.75K-21.22K
Interest Income00030-151021.51K7.57K13.13K13.66K13.35K23.83K25.35K3.6K204957541.24K1.72K
Interest Expense3.07K5754728295481.49K5868646118.36K3.5K3.83K6097.77K6.38K12.33K22.41K9.34K9.99K22.94K
Other Income/Expense-1.23M-1.05M-881.06K-1.23M-866.6K-744.21K-905.37K-557.45K52.91K-174.43K38.5K-125.21K-2.35K-153.16K59.34K-129.04K-61.15K-148.54K-22.36K-183.51K
Pretax Income-1.71M-1.83M-1.58M-1.96M-1.47M-1.19M-1.53M-1.46M-735.18K-2.86M-710.74K-521.4K-370.01K-3.65M-4.11M-7.22M-5.82M-4.42M-3.6M-4.69M
Pretax Margin %-21772.31%-739347.58%-5306.25%-5385.33%--78901.26%-2837.4%-1263.7%-314.88%-1861.73%-216.86%-82.65%-73.87%-616.38%-1003.29%-3938.42%-2454.82%-1112.98%-527.59%-472.51%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.71M-1.84M-1.58M-1.84M-1.47M-1.21M-1.53M12.88M-3.09M-2.86M-2.62M-2.68M-2.41M-3.65M-4.11M-7.22M-5.82M-4.42M-3.6M-4.69M
Net Margin %-21772.31%-740720.56%-5306.25%-5061.62%--79955.97%-2841.86%11171.9%-1322.23%-1861.73%-798.54%-424.04%-480.58%-616.38%-1003.29%-3938.42%-2454.82%-1112.98%-527.59%-472.51%
Net Income Growth %-16.22%-52.35%-3.09%-114.3%52.29%57.79%41.54%581.42%-28.25%21.76%36.29%62.95%58.67%17.46%-14.16%-53.97%-120.63%-108.2%-8.61%-50.58%
Net Income (Continuing)-1.71M-1.83M-1.58M-1.96M-1.47M-1.19M-1.53M-1.46M-735.18K-2.86M-710.74K-521.4K-370.01K-3.65M-4.11M-7.22M-5.82M-4.42M-3.6M-4.69M
Discontinued Operations0-3.4K0117.75K0-15.9K-2.4K1000K-1000K0-1000K-1000K-1000K0000000
Minority Interest00000000000000000000
EPS (Diluted)-1.20-1.54-1.67-2.40-1.80-1.48-1.8815.60-3.80-3.60-4.07-4.45-4.72-7.34-10.32-22.80-18.00-15.60-13.20-16.80
EPS Growth %33.33%-4.05%11.17%-115.38%52.63%58.89%53.81%450.56%19.49%50.95%60.56%80.48%73.78%52.95%21.82%-35.71%-90.68%-63.69%8.33%-16.67%
EPS (Basic)-1.20-1.54-1.67-2.56-1.80-1.45-1.8815.60-3.80-3.60-4.07-4.45-4.72-7.34-10.32-22.80-18.00-15.60-13.20-16.80
Diluted Shares Outstanding1.43M1.19M938.98K767.15K819.54K815.2K812.79K812.79K812.79K793.64K643.99K601.57K510.41K497.46K398.21K312.23K315.79K289.81K284.35K283.83K
Basic Shares Outstanding1.43M1.19M938.98K721.04K819.54K815.2K812.79K812.79K812.79K793.64K643.99K601.57K510.41K497.46K398.21K312.23K315.79K289.81K284.35K283.83K
Dividend Payout Ratio--------------------